D’Angelo (2016) reported that copper and iron interacted through ceruloplasmin, which is a copper-dependent oxidase, that contributes positively to iron transport in the plasma associated with transferrin, and recommended copper dosage for patients with cytopenia and/or low-grade MDS. This evidence concerns the gene TF and myelodysplastic syndrome.